1Vane JR, Bakhle YS, BoRing RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol, 1998, 38 : 97 - 120.
2Yamamoto T, Nozaki-Taguchi N. The role of cyclooxygenase-1 and -2 in the rat formalin test. Anesth Analg, 2002,94:962 - 967.
3Beiche F, Brune K, Geisslinger G, et al. Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis. Inflamm Res, 1998,47:482 - 487.
4Chandrasekharan NV, Dai H, Roos KL, et al. COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA, 2002, 99 : 13926 -13931.
5Schwab JM, Brechtel K, Nguyen TD, et al. Persistent accumulation of cyclooxygenase-1 ( COX-1 ) expressing microglia/macrophages and upregulation by endothelium following spinal cord injury. J Neuroimmunol, 2000, 111 : 122 -130.
6Svensson CI, Yaksh TL. The spinal phospholipase-cyclooxygenase-prostanoid cascade in nociceptive processing. Annu Rev Pharmacol Toxicol, 2002, 42 : 553 - 583.
7iDoi Y, Minami T, Nishizawa M, et al. Central nociceptive role of prostacyclin (IP) receptor induced by peripheral inflammation. Neuroreport, 2002, 13:93 - 96.
8Sinatra R. Role of COX-2 inhibitors in the evolution of acutepain management. J Pain Symptom Manage, 2002, 24 : S18- 27.
9Yamamoto T, Sakashita Y. COX-2 inhibitor prevents the development of hyperalgesia induced by intrathecal NMDA or AMPA. Neuroreport, 1998, 9 : 3869 - 3873.
10Bianchi M, Broggini M. Anti-hyperalgesic effects of nimesulide: studies in rats and humans. Int J Clin Pract Suppl,2002, 128 : 11 - 19.
8Codene TJ,Empel VI.The utility of excitatory amino acid (EAA) antagonists as analgesic agents.Ⅱ.Comparison of the antinociceptive activity of various classes of EAA antagonists in mechanical,thermal and chemical nociceptive tests.Pain,1994,59:353 ～363.
9Hunskaar S,Hole K.The formalin test in mice:dissociation between inflammatory and non-inflammatory.Pain,1987,30:103～114.
